Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Ultrasound guidance for volume management in patients with heart failure.

Bonios MJ, Kyrzopoulos S, Tsiapras D, Adamopoulos SN.

Heart Fail Rev. 2019 Oct 22. doi: 10.1007/s10741-019-09863-5. [Epub ahead of print] Review.

PMID:
31641978
2.

Balloon pulmonary angioplasty is a promising option in thalassemic patients with inoperable chronic thromboembolic pulmonary hypertension.

Karyofyllis P, Tsiapras D, Papadopoulou V, Diamantidis MD, Fotiou P, Demerouti E, Voudris V.

J Thromb Thrombolysis. 2018 Nov;46(4):516-520. doi: 10.1007/s11239-018-1720-4.

PMID:
30088118
3.

Genetic modifiers to the PLN L39X mutation in a patient with DCM and sustained ventricular tachycardia?

Sanoudou D, Kolokathis F, Arvanitis D, Al-Shafai K, Krishnamoorthy N, Buchan RJ, Walsh R, Tsiapras D, Barton PJ, Cook SA, Kremastinos D, Yacoub M.

Glob Cardiol Sci Pract. 2015 Jul 3;2015(2):29. doi: 10.5339/gcsp.2015.29. eCollection 2015. No abstract available.

4.

Corrigendum: Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naïve users (smokers).

Farsalinos KE, Spyrou A, Stefopoulos C, Tsimopoulou K, Kourkoveli P, Tsiapras D, Kyrzopoulos S, Poulas K, Voudris V.

Sci Rep. 2015 Sep 4;5:13506. doi: 10.1038/srep13506.

5.

Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naïve users (smokers).

Farsalinos KE, Spyrou A, Stefopoulos C, Tsimopoulou K, Kourkoveli P, Tsiapras D, Kyrzopoulos S, Poulas K, Voudris V.

Sci Rep. 2015 Jun 17;5:11269. doi: 10.1038/srep11269. Erratum in: Sci Rep. 2015;5:13506.

6.

Mid-ventricular hypertrophic obstructive cardiomyopathy complicated by an apical aneurysm, presenting as ventricular tachycardia.

Petrou E, Kyrzopoulos S, Sbarouni E, Tsiapras D, Voudris V.

J Cardiovasc Ultrasound. 2014 Sep;22(3):158-9. doi: 10.4250/jcu.2014.22.3.158. Epub 2014 Sep 29. No abstract available.

7.

Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes.

Farsalinos KE, Tsiapras D, Kyrzopoulos S, Savvopoulou M, Voudris V.

BMC Cardiovasc Disord. 2014 Jun 23;14:78. doi: 10.1186/1471-2261-14-78.

8.

Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers.

Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V.

Int J Environ Res Public Health. 2014 Apr 22;11(4):4356-73. doi: 10.3390/ijerph110404356.

9.

Impact of flavour variability on electronic cigarette use experience: an internet survey.

Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Spyrou A, Voudris V.

Int J Environ Res Public Health. 2013 Dec 17;10(12):7272-82. doi: 10.3390/ijerph10127272.

10.

Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells.

Farsalinos KE, Romagna G, Allifranchini E, Ripamonti E, Bocchietto E, Todeschi S, Tsiapras D, Kyrzopoulos S, Voudris V.

Int J Environ Res Public Health. 2013 Oct 16;10(10):5146-62. doi: 10.3390/ijerph10105146.

11.

Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking.

Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V.

Subst Abuse. 2013 Sep 3;7:139-46. doi: 10.4137/SART.S12756. eCollection 2013.

12.

Evaluation of electronic cigarette use (vaping) topography and estimation of liquid consumption: implications for research protocol standards definition and for public health authorities' regulation.

Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V.

Int J Environ Res Public Health. 2013 Jun 18;10(6):2500-14. doi: 10.3390/ijerph10062500.

13.

Echocardiographic evaluation of aortic valve stenosis: problems and pitfalls.

Kouris NT, Tsiapras DP, Olympios CD.

Hellenic J Cardiol. 2012 Jul-Aug;53(4):255-62. No abstract available.

14.

A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy.

Haghighi K, Kolokathis F, Gramolini AO, Waggoner JR, Pater L, Lynch RA, Fan GC, Tsiapras D, Parekh RR, Dorn GW 2nd, MacLennan DH, Kremastinos DT, Kranias EG.

Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1388-93. Epub 2006 Jan 23.

15.

Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human.

Haghighi K, Kolokathis F, Pater L, Lynch RA, Asahi M, Gramolini AO, Fan GC, Tsiapras D, Hahn HS, Adamopoulos S, Liggett SB, Dorn GW 2nd, MacLennan DH, Kremastinos DT, Kranias EG.

J Clin Invest. 2003 Mar;111(6):869-76.

Supplemental Content

Loading ...
Support Center